MOGwAI : A Randomized Double Blind, Placebo-Controlled Multicenter Phase 3 Trial to Evaluate the Efficacy of Azathioprine for Prevention of Relapse in Patients with Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease after a First Attack
MULTIPLE SCLEROSIS JOURNAL(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要